메뉴 건너뛰기
Revista Espanola de Cardiologia
Volumn 66, Issue 9, 2013, Pages 748-749
Adequate cholesterol levels in coronary heart disease and diabetic patients. Analysis according to medical specialty and autonomous communities;Cifras de colesterol adecuadas en pacientes coronarios y diabéticos. Análisis según especialidades médicas y comunidades autónomas
Author keywords

[No Author keywords available]
Indexed keywords

CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;
EID: 84936129359     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/j.recesp.2013.04.012     Document Type: Letter
Times cited : (8)
References (6)
  • 1
    • 4444382796 scopus 로고    scopus 로고
    • Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study
    • DOI 10.1016/S0140-6736(04)17018-9, PII S0140673604170189
    • S. Yusuf, S. Hawken, S. Ounpuu, T. Dans, A. Avenzum, and F. Lanas Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study Lancet 364 2004 937 952 (Pubitemid 39208455)
    • (2004) Lancet , vol.364 , Issue.9438 , pp. 937-952
    • Yusuf, P.S.1    Hawken, S.2    Ounpuu, S.3    Dans, T.4    Avezum, A.5    Lanas, F.6    McQueen, M.7    Budaj, A.8    Pais, P.9    Varigos, J.10    Lisheng, L.11
  • 2
    • 26244432388 scopus 로고    scopus 로고
    • Efficacy and safety of cholesterol-lowering treatment: Prospective meta-analysis of data from 90.056 participants in 14 randomized trials of statins
    • C. Baigent, A. Keech, P.M. Kearney, L. Blackwell, G. Buck, and C. Pollicino Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90.056 participants in 14 randomized trials of statins Lancet 366 2005 1267 1278
    • (2005) Lancet , vol.366 , pp. 1267-1278
    • Baigent, C.1    Keech, A.2    Kearney, P.M.3    Blackwell, L.4    Buck, G.5    Pollicino, C.6
  • 3
    • 34247842857 scopus 로고    scopus 로고
    • Prospects for atherosclerosis regression through increase in high-density lipoprotein and other emerging therapeutic targets
    • DOI 10.1136/hrt.2005.066050
    • J.M.S. Lee, and R.P. Choudhury Prospects for atherosclerosis regression through increase in high density lipoprotein and other emerging therapeutic targets Heart 93 2007 559 564 (Pubitemid 46707106)
    • (2007) Heart , vol.93 , Issue.5 , pp. 559-564
    • Lee, J.M.S.1    Choudhury, R.P.2
  • 4
    • 79953280607 scopus 로고    scopus 로고
    • Prevalencia y características de las anomalías lipídicas de pacientes tratados con estatinas en prevención primaria y secundaria en España. Estudio DYSIS-España
    • J.R. González-Juanatey, J. Millán, E. Alegría, C. Guijarro, J.V. Lozano, and G.C. Vitale Prevalencia y características de las anomalías lipídicas de pacientes tratados con estatinas en prevención primaria y secundaria en España. Estudio DYSIS-España Rev Esp Cardiol 64 2011 286 294
    • (2011) Rev Esp Cardiol , vol.64 , pp. 286-294
    • González-Juanatey, J.R.1    Millán, J.2    Alegría, E.3    Guijarro, C.4    Lozano, J.V.5    Vitale, G.C.6
  • 6
    • 79960539641 scopus 로고    scopus 로고
    • ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
    • Z. Reiner, A.L. Catapano, G. De Backer, I. Graham, M.R. Taskinen, and O. Wiklund ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS) Eur Heart J 32 2011 1769 1818
    • (2011) Eur Heart J , vol.32 , pp. 1769-1818
    • Reiner, Z.1    Catapano, A.L.2    De Backer, G.3    Graham, I.4    Taskinen, M.R.5    Wiklund, O.6

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.